关注
Kochurani K. Johnson
Kochurani K. Johnson
Massachusetts General Hospital, Harvard Medical School
在 mgh.harvard.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Preclinical cancer theranostics—from nanomaterials to clinic: the missing link
KK Johnson, P Koshy, JL Yang, CC Sorrell
Advanced Functional Materials 31 (43), 2104199, 2021
452021
A novel method for immobilization of proteins via entrapment of magnetic nanoparticles through epoxy cross-linking
T Iype, J Thomas, S Mohan, KK Johnson, LE George, LA Ambattu, A Bhati, ...
Analytical biochemistry 519, 42-50, 2017
402017
TM1-IR680 peptide for assessment of surgical margin and lymph node metastasis in murine orthotopic model of oral cancer
AA Suganya S, KJ Kochurani, MG Nair, JM Louis, S Sankaran, ...
Scientific reports 6 (1), 36726, 2016
132016
Impact of morphology and collagen-functionalization on the redox equilibria of nanoceria for cancer therapies
WF Chen, CMDS Malacco, R Mehmood, KK Johnson, JL Yang, ...
Materials Science and Engineering: C 120, 111663, 2021
92021
Live detection and purification of cells based on the expression of a histone chaperone, HIRA, using a binding peptide
KJ Kochurani, AA Suganya, MG Nair, JM Louis, A Majumder, S Kumar K, ...
Scientific Reports 5 (1), 17218, 2015
62015
Theranostic Activity of Ceria-Based Nanoparticles toward Parental and Metastatic Melanoma: 2D vs 3D Models
K K. Johnson, C Kopecky, P Koshy, Y Liu, M Devadason, J Holst, ...
ACS Biomaterials Science & Engineering 9 (2), 1053-1065, 2023
52023
Nanoceria for ROS-Mediated Cancer Therapy: A Receptor-Targeted Theranostic Approach
K Kandamkulathy Johnson
UNSW Sydney, 2022
22022
ROS‐mediated anticancer effects of EGFR‐targeted nanoceria
KK Johnson, P Koshy, C Kopecky, M Devadason, J Biazik, X Zheng, ...
Journal of Biomedical Materials Research Part A 112 (5), 754-769, 2024
12024
系统目前无法执行此操作,请稍后再试。
文章 1–8